During the past decade, The fourth hospital of Hebei Medical University conducted 138 clinical trials. In the 10-year time frame, 138 clinical trials started and 11 clinical trials were completed, i.e. on average, 8% percent of trials that started reached the finish line to date. In the past 5 years, 76 clinical trials started and 8 clinical trials were completed. i.e. 10.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The fourth hospital of Hebei Medical University" #1 sponsor was "Hebei Medical University Fourth Hospital" with 13 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 10 trials sponsored, "Hoffmann-La Roche" with 10 trials sponsored, "Jiangsu HengRui Medicine Co., Ltd." with 9 trials sponsored and "Hebei Medical University" with 9 trials sponsored. Other sponsors include 104 different institutions and companies that sponsored additional 77 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The fourth hospital of Hebei Medical University" #1 collaborator was "Hebei Medical University Fourth Hospital" with 18 trials as a collaborator, "Tianjin Medical University Cancer Institute and Hospital" with 8 trials as a collaborator, "Chinese PLA General Hospital" with 6 trials as a collaborator, "Fudan University" with 6 trials as a collaborator and "Guangdong Provincial People's Hospital" with 5 trials as a collaborator. Other collaborators include 239 different institutions and companies that were collaborators in the rest 159 trials.

According to Clinical.Site data, the most researched conditions in "The fourth hospital of Hebei Medical University" are "Breast Cancer" (14 trials), "Gastric Cancer" (12 trials), "Non-small Cell Lung Cancer" (7 trials), "Advanced Solid Tumor" (5 trials) and "Breast Neoplasms" (5 trials). Many other conditions were trialed in "The fourth hospital of Hebei Medical University" in a lesser frequency.

Most popular intervention types in "The fourth hospital of Hebei Medical University" are "Drug" (136 trials), "Biological" (9 trials), "Procedure" (8 trials), "Other" (4 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Capecitabine" (7 trials), "Docetaxel" (7 trials), "Anlotinib" (6 trials) and "Cyclophosphamide" (6 trials). Other intervention names were less common.

The vast majority of trials in "The fourth hospital of Hebei Medical University" are 132 trials for "All" genders, 22 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 77 active trials in "The fourth hospital of Hebei Medical University". 3 are not yet recruiting, 54 are recruiting, 18 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 27 completed trials in The fourth hospital of Hebei Medical University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The fourth hospital of Hebei Medical University, 21 "Phase 1" clinical trials were conducted, 54 "Phase 2" clinical trials and 66 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 12 trials that are defined as “Not Applicable".

The fourth hospital of Hebei Medical University has several departments that took part in Clinical trials: "Fourth Hospital of Hebei Medical University Breast cancer department" - 2 trials